Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement
Gao S, Corso C, Wang E, Blasberg J, Boffa D, Detterbeck F, Kim A. Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e470. DOI: 10.1016/j.ijrobp.2016.06.1811.Peer-Reviewed Original ResearchResection is safe for patients with stage IIIA NSCLC undergoing multimodality therapy
Lushaj E, Julliard W, Bretl T, Badami A, Macke R, Blasberg J, Maloney J. Resection is safe for patients with stage IIIA NSCLC undergoing multimodality therapy. Cancer Treatment And Research Communications 2016, 5: 22-25. DOI: 10.1016/j.ctrc.2015.12.002.Peer-Reviewed Original ResearchNon-small cell lung cancerIIIA non-small cell lung cancerStage IIIA non-small cell lung cancerStage I non-small cell lung cancerVideo-assisted thoracoscopic surgeryStage IIIA patientsIIIA patientsStage IStage IIMultimodality therapySurvival rateMedian hospital lengthOverall survival rateResults Mean ageCell lung cancerPost-treatment survivalInitial therapyAdvanced diseaseHospital lengthNeoadjuvant radiationPerioperative morbidityPulmonary resectionThoracoscopic surgeryOptimal therapySurgical intervention